Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
New York Auto Show Puts Big Focus on Electric Vehicles
Lisa Whalen, Automotive and Mobility Analyst at Morning Consult, joined Cheddar News' Closing Bell to break down the famed auto show's emphasis on electric vehicles this year, reflecting a shift toward electrification in the automotive industry.
Paving the Way for Women in the Spirits Industry; Sustainability That Gives Back to The Planet and Social Causes
On this episode of ChedHER, Amira Rasool, CEO and Founder of The Folklore, discusses her $1.7 million pre-seed funding round and why she's being intentional about the investors she's working with; Brittany Merrill-Yeng, co-founder Skrewball Whiskey, reveals the origins of Skrewball Whisky, experiencing a period of rapid growth, and navigating a male-dominated industry; Suz Hernandez, Owner of MamaP, breaks down how her company is combining eco-friendly and sustainable products with a mission to donate to non-profits that help people and the planet.
State of Lactation Support in the U.S.; Perks of Having a Business Mentor
On this episode of ChedHER: CEO of The Lactation Network breaks down how they are expanding access to lactation support for families nationwide; CEO of Vanta explains the importance of a security team for startups; Midwest Divison Area Manager at JPMorgan Chase discusses the perks of having a business mentor.
Load More